Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 208

    Lupin recalls 6,752 bottles of Testosterone topical solution from US

    Lupin recalls 6,752 bottles of Testosterone topical solution from US

    Medical Dialogues Bureau5 Nov 2018 10:15 AM IST
    The reason for the recall is "Defective Container: Repetitive complaints received indicating pump not working,"New Delhi: The US arm of drug firm...
    Aurobindo recalls Irbesartan drug in US citing cancer risk

    Aurobindo recalls Irbesartan drug in US citing cancer risk

    Medical Dialogues Bureau5 Nov 2018 10:00 AM IST
    "Aurobindo Pharma Limited has notified ScieGen Pharmaceuticals, Inc. of the recall and is arranging for the return of all available Irbesartan drug...
    Torrent Pharma Q2 net profit dips 12 percent to Rs 179 crore

    Torrent Pharma Q2 net profit dips 12 percent to Rs 179 crore

    Medical Dialogues Bureau5 Nov 2018 9:15 AM IST
    New Delhi: Drug firm Torrent Pharmaceuticals has reported a 12.25 per cent dip in its consolidated net profit to Rs 179 crore for the quarter ended...
    FDA approves Hyrimoz- Novartis copy of AbbVie bestseller Humira

    FDA approves Hyrimoz- Novartis copy of AbbVie bestseller Humira

    Medical Dialogues Bureau5 Nov 2018 9:00 AM IST
    New Delhi: The U.S. Food and Drug Administration (FDA) has approved Novartis AG's copy of Humira, the world's bestselling prescription medicine...
    FDA permits marketing of two devices that detect parathyroid tissue in real-time during surgery

    FDA permits marketing of two devices that detect parathyroid tissue in real-time during surgery

    Medical Dialogues Bureau4 Nov 2018 9:36 AM IST
    New Delhi: The U.S. Food and Drug Administration permitted marketing of two devices that provide real-time location of parathyroid tissue during...
    Medicover Launches Fertility clinics in Hyderabad

    Medicover Launches Fertility clinics in Hyderabad

    Medical Dialogues Bureau4 Nov 2018 9:20 AM IST
    Hyderabad: European healthcare provider Medicover planned to open 36 fertility clinics across the country by December 2019, a senior company official...
    Alkermes depression treatment fails to get FDA panel backing

    Alkermes' depression treatment fails to get FDA panel backing

    Medical Dialogues Bureau4 Nov 2018 9:00 AM IST
    New Delhi: An advisory panel to the U.S. Food and Drug Administration has recently voted against approving Alkermes Plc's treatment for depression in...
    FDA panel recommends Sages postpartum depression treatment

    FDA panel recommends Sage's postpartum depression treatment

    Medical Dialogues Bureau4 Nov 2018 9:00 AM IST
    Zulresso, which is administered as a 60-hour intravenous infusion, targets hormonal changes in new mothers, differentiating it as a drug for...
    HC impleads online medicine traders in plea seeking ban on e-pharmacies

    HC impleads online medicine traders in plea seeking ban on e-pharmacies

    Medical Dialogues Bureau3 Nov 2018 12:43 PM IST
    E-pharmacy was an initiative to help the caregivers select the most appropriate health care services at the best possible price.Chennai: The Madras...
    Lupin Q2 net profit drops 41.5 Percent to Rs 266 Crore

    Lupin Q2 net profit drops 41.5 Percent to Rs 266 Crore

    Medical Dialogues Bureau3 Nov 2018 10:11 AM IST
    New Delhi: Drug maker Lupin has recently reported a 41.5 per cent decline in its consolidated net profit at Rs 266 crore for the second quarter ended...
    Proteinx tied with Inbody to create awareness on  Muscle Health

    Proteinx tied with Inbody to create awareness on  Muscle Health

    Medical Dialogues Bureau3 Nov 2018 9:20 AM IST
    71% of Indians have Poor Muscle Health, 68% have low Protein levels – says InBody study in association with IPSOS. Poor muscle mass could lead to...
    Mercks Blockbuster Drug Keytruda Approved by FDA

    Merck's Blockbuster Drug Keytruda Approved by FDA

    Medical Dialogues Bureau3 Nov 2018 9:15 AM IST
    New Delhi: Merck announced that the U.S. Food and Drug Administration (FDA) has approved Keytruda, Merck’s anti-PD-1 therapy, in combination with...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok